EN PL
CASE REPORT
Systemic allergic reaction to sulfasalazine treatment – DRESS syndrome in the course of juvenile idiopathic arthritis
 
More details
Hide details
 
Online publication date: 2012-03-02
 
 
Reumatologia 2012;50(1):66-71
 
KEYWORDS
ABSTRACT
DRESS syndrome (drug rash with eosinophilia and systemic symptoms) is a type of severe drug hypersensitivity reaction. It is characterized by maculopapular rash, haematological disorders (eosinophilia or atypical lymphocytes) and the involvement of internal organs (usually liver, kidney, lung, heart) (Table I, II, Fig. 1–3). There are often fever, lymphadenopathy, and facial oedema. Mortality is 10–38%. The pathogenesis, not fully understood, is multifactorial (viral infections, HHV-6, EBV, immunomodulatory effects of certain drugs, metabolic disorders, autoimmune diseases). The medical history remains the most important factor for the diagnosis. The treatment consists of discontinuation of the drug that caused an allergic reaction. In severe cases, corticosteroids and immunoglobulins are useful.
This article describes the case of 5-year-old girl, with a seven-week history of treatment with sulphasalazine due to isolated pain of the knee, and then symptoms of DRESS syndrome with a predominant clinical picture of liver dysfunction. The authors present diagnostic and therapeutic difficulties in the diagnosis of this syndrome, and the clinical course that required a wide differential diagnosis.
REFERENCES (31)
1.
Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996; 1: 250-257.  .
 
2.
Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011; 124: 588-597.  .
 
3.
Lis-Święty A, Brzezińska-Wcisło L, Bergler-Czop B. Osutka polekowa z eozynofilią i objawami układowymi – zespół nadwrażliwości indukowany lekami. Post Dermatol Alergol 2010; 27: 297-302.  .
 
4.
Bogus-Buczyńska I, Kuna P. Alergia na leki. Trudny problem dla lekarzy, niebezpieczeństwo dla chorych. Terapia 2005; 14: 13-17.  .
 
5.
Michel F, Navellou JC, Ferraud D, et al. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. J Bone Spine 2005; 72: 82-85.  .
 
6.
Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 1950; 242: 897-898.  .
 
7.
Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137: 301-304.  .
 
8.
Descamps V, Ben Sa..Id B, Sassolas B, et al. Management of drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol 2010; 137: 703-708.  .
 
9.
Teo L, Tan E. Sulphasalazine-induced DRESS. Singapore Med J 2006; 47: 237-239. .
 
10.
Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1-8. .
 
11.
Voltolini S, Bignardi D, Minale P, et al. Phenobarbital-induced DiHS and ceftriaxone hypersensitivity reaction: a case of multiple drug allergy. Eur Ann Allergy Clin Immunol 2009; 41: 62-63. .
 
12.
Szewczuk-Bogusławska M, Trypka E. Zespoły nadwrażliwości podczas stosowania leków przeciwpadaczkowych u osób w wieku podeszłym. Psychogeriatr Pol 2006; 3: 221-227 .
 
13.
Boey ML, Lee E, Feng PH. Sulphasalazine in rheumatoid arthritis. Singapore Med J 1988; 29: 285-288. .
 
14.
Pearl RK, Nelson RL, Prasad ML, et al. Serious complications of sulfasalazine. Dis Colon Rectum 1986; 29: 201-202. .
 
15.
Pin~ana E, Lei SH, Merino R, et al. DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of herpevirus 6 in an 11-year-old caucasian boy. J Clin Pharm Ther 2010; 36: 365-370. .
 
16.
Balci DD, Peker E, Duran N, et al. Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation. Cutan Ocul Toxicol 2009; 28: 45-47. .
 
17.
Augusto JF, Sayegh J, Simon A, et al. A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis. Nephrol Dial Transplant 2009; 24: 2940-2942. .
 
18.
Mennicke M, Zawodniak A, Keller M, et al. Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant 2009; 9: 2197-2202. .
 
19.
Jennings PE, Blandford RL, Rosenthal FD. Acute sulphasalazine hepatotoxicity. Postgrad Med J 1986; 62: 305-306. .
 
20.
Farr M, Symmons DP, Bacon PA. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine. Ann Rheum Dis 1985; 44: 798-800. .
 
21.
Tung Y, Escutia B, Blanes M, et al. Sulfasalazine-induced hypersensitivity syndrome associated with human herpesvirus 6 reactivation and induction of antiphospholipid syndrome. Actas Dermosifiliogr 2011; 102: 537-540. .
 
22.
Caspi D, Fuchs D, Yaron M. Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis. Ann Rheum Dis 1992; 51: 275-276. .
 
23.
Dubey S, Adebajo AO. Lymphoproliferative disorder due to sulphasalazine. BMJ Case Rep 2009; 2009. pii: bcr06.2008.0038. .
 
24.
Gutkowski K, Hartley M, Kamińska E. Hepatotoksyczność leków – mechanizmy sprawcze. Przegl Gastroenterol 2008; 3: 271-275. .
 
25.
Pessayre D. Role of reactive metabolites in drug-induced hepatitis. J Hepatol 1995; 23 Suppl 1: 16-24. .
 
26.
Grech V, Buttigieg T, Portelli A, et al. Kawasaki disease presenting as hepatitis. Ann Trop Paediatr 2007; 27: 303-306. .
 
27.
Gietka P, Wieteska-Klimczak A, Smorczewska-Kiljan A i wsp. Reaktywne zespoły hemofagocytarne u dzieci z chorobami reumatycznymi. Reumatologia 2011; 49: 96-107. .
 
28.
Vyse T, So AK. Sulphasalazine induced autoimmune syndrome. Br J Rheumatol 1992; 31: 115-116. .
 
29.
Borg AA. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol 1995; 34: 1097-1098. .
 
30.
Laversuch CJ, Collins DA, Charles PJ, et al. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol 1995; 34: 435-439. .
 
31.
Schaller J, Beckwith B, Wedgwood RJ. Hepatic involvement in juvenile rheumatoid arthritis. J Pediatr 1970; 77: 203-210.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top